These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 36916659)
1. Tumor-Targeting Nanoassembly for Enhanced Colorectal Cancer Therapy by Eliminating Intratumoral Li X; Ma Y; Xin Y; Ma F; Gao H ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36916659 [No Abstract] [Full Text] [Related]
2. Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer. Li X; Niu J; Deng L; Yu Y; Zhang L; Chen Q; Zhao J; Wang B; Gao H Acta Biomater; 2024 Jan; 173():432-441. PubMed ID: 37984629 [TBL] [Abstract][Full Text] [Related]
3. Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against Su M; Wen X; Yu Y; Li N; Li X; Qu X; Elsabahy M; Gao H J Mater Chem B; 2024 Apr; 12(16):3947-3958. PubMed ID: 38586917 [TBL] [Abstract][Full Text] [Related]
4. Remotely Controllable Supramolecular Nanomedicine for Drug-Resistant Colorectal Cancer Therapy Caused by Fusobacterium nucleatum. Yan X; Xin Y; Yu Y; Li X; Li B; Elsabahy M; Zhang J; Ma F; Gao H Small Methods; 2024 Mar; 8(3):e2301309. PubMed ID: 38018349 [TBL] [Abstract][Full Text] [Related]
5. Antibacterial tellurium-containing polycarbonate drug carriers to eliminate intratumor bacteria for synergetic chemotherapy against colorectal cancer. Hu J; Ran S; Huang Z; Liu Y; Hu H; Zhou Y; Ding X; Yin J; Zhang Y Acta Biomater; 2024 Jul; ():. PubMed ID: 38964527 [TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism. Ou S; Wang H; Tao Y; Luo K; Ye J; Ran S; Guan Z; Wang Y; Hu H; Huang R Front Cell Infect Microbiol; 2022; 12():1020583. PubMed ID: 36523635 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer. Yamamoto S; Kinugasa H; Hirai M; Terasawa H; Yasutomi E; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Harada K; Hiraoka S; Nouso K; Tanaka T; Teraishi F; Fujiwara T; Okada H J Gastroenterol Hepatol; 2021 Jul; 36(7):1869-1876. PubMed ID: 33242360 [TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498 [TBL] [Abstract][Full Text] [Related]
9. Efficient nuclear drug translocation and improved drug efficacy mediated by acidity-responsive boronate-linked dextran/cholesterol nanoassembly. Zhu JY; Lei Q; Yang B; Jia HZ; Qiu WX; Wang X; Zeng X; Zhuo RX; Feng J; Zhang XZ Biomaterials; 2015 Jun; 52():281-90. PubMed ID: 25818434 [TBL] [Abstract][Full Text] [Related]
10. [Advances on the treatment of Wang H; Hou X; Liu J; Yang C Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3670-3680. PubMed ID: 37805845 [No Abstract] [Full Text] [Related]
11. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota. LaCourse KD; Zepeda-Rivera M; Kempchinsky AG; Baryiames A; Minot SS; Johnston CD; Bullman S Cell Rep; 2022 Nov; 41(7):111625. PubMed ID: 36384132 [TBL] [Abstract][Full Text] [Related]
12. Sodium New Houttuyfonate Inhibits Cancer-Promoting Jia F; Yu Q; Zhao L; Shen Y; Guo H; He F Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551597 [TBL] [Abstract][Full Text] [Related]
13. Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L Front Immunol; 2021; 12():658681. PubMed ID: 34093546 [No Abstract] [Full Text] [Related]
14. Size-tunable nanogels for cascaded release of metronidazole and chemotherapeutic agents to combat Fusobacterium nucleatum-infected colorectal cancer. Xie S; Wei L; Liu Y; Meng J; Cao W; Qiu B; Li X J Control Release; 2024 Jan; 365():16-28. PubMed ID: 37956925 [TBL] [Abstract][Full Text] [Related]
15. Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression. Jia F; Yu Q; Wang R; Zhao L; Yuan F; Guo H; Shen Y; He F Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674985 [TBL] [Abstract][Full Text] [Related]
16. Yang Z; Ji G Oncol Lett; 2019 Aug; 18(2):975-982. PubMed ID: 31423156 [TBL] [Abstract][Full Text] [Related]
17. Modulation of Intratumoral Qu X; Yin F; Pei M; Chen Q; Zhang Y; Lu S; Zhang X; Liu Z; Li X; Chen H; Zhang Y; Qin H ACS Nano; 2023 Jun; 17(12):11466-11480. PubMed ID: 37201179 [TBL] [Abstract][Full Text] [Related]